DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (Amex: AXK) announced today that research investigators at the Denver Health Medical Center presented results of a study using the company’s BACcel™ rapid diagnostic system. They presented results of a retrospective study at the joint sessions of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC, www.icaac.org) and the Infectious Diseases Society of America (IDSA, www.idsociety.org), October 25-29 in Washington, DC. Connie S. Price, MD led the study. She is the Chief of Infectious Diseases, Denver Health, and Assistant Professor of Medicine at the University of Colorado School of Medicine. The purpose of the study was to estimate the potential impact of rapid diagnosis on reducing the use of suboptimal and inactive therapy caused by delays in obtaining results from standard lab cultures.
